Ankur Vaidya

Dr. Ankur Vaidya

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2012 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
AJAbhishek Kumar Jain
Abhishek Kumar Jain
AVAnkur Vaidya
Ankur Vaidya
RVRavichandran Veerasamy
Ravichandran Veerasamy
SKSushil Kumar Kashaw
Sushil Kumar Kashaw
RARam Kishore Agrawal
Ram Kishore Agrawal

24 April 2013 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
AJAbhishek Kumar Jain
Abhishek Kumar Jain
SSSimant Sharma
Simant Sharma
AVAnkur Vaidya
Ankur Vaidya
RVRavichandran Veerasamy
Ravichandran Veerasamy
RARam Kishore Agrawal
Ram Kishore Agrawal

8 May 2021 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
PYPoonam Yadav
Poonam Yadav
RYRamakant Yadav
Ramakant Yadav
SJShweta Jain
Shweta Jain
AVAnkur Vaidya
Ankur Vaidya

27 September 2020 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
AVAnkur Vaidya
Ankur Vaidya
DPDevender Pathak
Devender Pathak
KSKamal Shah
Kamal Shah

Verified
Journal Article
Open access
PDF file
SJShweta Jain
Shweta Jain
MUDIT KUMARMUDIT KUMAR
MUDIT KUMAR
PKPushpendra Kumar
Pushpendra Kumar
JVJyoti Verma
Jyoti Verma
Jessica M. RosenholmJessica M. Rosenholm
Jessica M. Rosenholm
AVAnkur Vaidya
Ankur Vaidya
Lipid nanoparticles (LNPs) are spherical vesicles composed of ionizable lipids that are neutral at physiological pH. Despite their benefits, unmodified LNP drug delivery systems have substantial drawbacks, including a lack of targeted selectivity, a short blood circulation period, and in vivo instability. lipid–polymer hybrid nanoparticles (LPHNPs) are the next generation of nanoparticles, having the combined benefits of polymeric nanoparticles and liposomes. LPHNPs are being prepared from both natural and synthetic polymers with various techniques, including one- or two-step methods, emulsification solvent evaporation (ESE) method, and the nanoprecipitation method. Varieties of LPHNPs, including monolithic hybrid nanoparticles, core–shell nanoparticles, hollow core–shell nanoparticles, biomimetic lipid–polymer hybrid nanoparticles, and polymer-caged liposomes, have been investigated for various drug delivery applications. However, core–shell nanoparticles having a polymeric core surrounded by a highly biocompatible lipid shell are the most commonly explored LPHNPs for the treatment of various diseases. In this review, we will shed light on the composition, methods of preparation, classification, surface functionalization, release mechanism, advantages and disadvantages, patents, and clinical trials of LPHNPs, with an emphasis on core–shell-structured LPHNPs.

1 November 2009 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
AVAnkur Vaidya
Ankur Vaidya
AJAviral Jain
Aviral Jain
PKPiush Khare
Piush Khare
RARam K. Agrawal
Ram K. Agrawal
SJSanjay K. Jain
Sanjay K. Jain